Immunic, Inc. Reports Year End 2021 Financial Results and Highlights Recent Activity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)
February 24, 2022 6:49 AM ESTImmunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
... More